Evidence map›Paper›PMID 27510972›Full record

ArticleDevelopment (Cambridge, England)2016

A novel small molecule that disrupts a key event during the oocyte-to-embryo transition in C. elegans.

Steven E Weicksel, Assaf Mahadav, Mark Moyle, Patricia G Cipriani, Michelle Kudron, Zachary Pincus, Shirin Bahmanyar, Laura Abriola, Janie Merkel, Michelle Gutwein and 4 more

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. C22 disrupts embryogenesis and extendsFrontiers in physiology · 2023
    Article
  5. Meta-Analysis ofFrontiers in microbiology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Steven E WeickselDept. of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
Assaf MahadavDept. of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA Center for Genomics and Systems Biology, Dept. of Biology, New York University, New York, NY 10003, USA.
Mark MoyleDept. of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA.
Patricia G CiprianiCenter for Genomics and Systems Biology, Dept. of Biology, New York University, New York, NY 10003, USA.
Michelle KudronDept. of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
Zachary PincusDept. of Developmental Biology and Dept. of Genetics, Washington University in St Louis, St Louis, MO 63110, USA.
Shirin BahmanyarDept. of Molecular Cell and Developmental Biology, Yale University, New Haven, CT 06520, USA.
Laura AbriolaYale Center for Molecular Discovery, West Haven, CT 06516, USA.
Janie MerkelYale Center for Molecular Discovery, West Haven, CT 06516, USA.
Michelle GutweinCenter for Genomics and Systems Biology, Dept. of Biology, New York University, New York, NY 10003, USA.
Anita G FernandezDept. of Biology, Fairfield University, Fairfield, CT 06824, USA.
Fabio PianoCenter for Genomics and Systems Biology, Dept. of Biology, New York University, New York, NY 10003, USA Division of Biological Sciences, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates fp1@nyu.edu kcg1@nyu.edu valerie.reinke@yale.edu.
Kristin C GunsalusCenter for Genomics and Systems Biology, Dept. of Biology, New York University, New York, NY 10003, USA Division of Biological Sciences, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates fp1@nyu.edu kcg1@nyu.edu valerie.reinke@yale.edu.
Valerie ReinkeDept. of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA fp1@nyu.edu kcg1@nyu.edu valerie.reinke@yale.edu.ORCID 0000-0002-8967-2756

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Resource ProjectU41HG007355 · NHGRI · UNIVERSITY OF WASHINGTON · PI WATERSTON, ROBERT H · 2013 to 2021
$20.8M
Global Identification of Transcription Factor Binding Sites in C. elegansU01HG004267 · NHGRI · YALE UNIVERSITY · PI SNYDER, MICHAEL P. · 2007 to 2011
$8.1M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Training in Genomics and Proteomics TechnologiesT32HG003198 · NHGRI · YALE UNIVERSITY · PI BREAKER, RONALD R · 2004 to 2015
$4.9M
A Systematic RNAi-based Map of C. elegans EmbryogenesisR01HD046236 · NICHD · NEW YORK UNIVERSITY · PI GUNSALUS, KRISTIN C, PIANO, FABIO · 2004 to 2013
$4.5M
Deciphering mechanisms governing functional partitioning of the C. elegans genomeR01GM108663 · NIGMS · YALE UNIVERSITY · PI REINKE, VALERIE J · 2014 to 2017
$1.3M
Discover determinants of individual longevity and health in C. elegansR00AG042487 · NIA · WASHINGTON UNIVERSITY · PI PINCUS, ZACHARY · 2014 to 2016
$740k
Discover determinants of individual longevity and health in C. elegansK99AG042487 · NIA · YALE UNIVERSITY · PI PINCUS, ZACHARY · 2012 to 2013
$141k
NCATS NIH HHS UL1 TR001863NHGRI NIH HHS T32 HG003198NHGRI NIH HHS U01 HG004267NHGRI NIH HHS U41 HG007355NIA NIH HHS K99 AG042487NIA NIH HHS R00 AG042487NICHD NIH HHS R01 HD046236NIGMS NIH HHS R01 GM108663NIH HHS P40 OD010440
6 · The paper itself

Abstract

The complex cellular events that occur in response to fertilization are essential for mediating the oocyte-to-embryo transition. Here, we describe a comprehensive small-molecule screen focused on identifying compounds that affect early embryonic events in Caenorhabditis elegans We identify a single novel compound that disrupts early embryogenesis with remarkable stage and species specificity. The compound, named C22, primarily impairs eggshell integrity, leading to osmotic sensitivity and embryonic lethality. The C22-induced phenotype is dependent upon the upregulation of the LET-607/CREBH transcription factor and its candidate target genes, which primarily encode factors involved in diverse aspects of protein trafficking. Together, our data suggest that in the presence of C22, one or more key components of the eggshell are inappropriately processed, leading to permeable, inviable embryos. The remarkable specificity and reversibility of this compound will facilitate further investigation into the role and regulation of protein trafficking in the early embryo, as well as serve as a tool for manipulating the life cycle for other studies such as those involving aging.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsEmbryonic DevelopmentEmbryo, NonmammalianOocytesTranscription FactorsCaenorhabditis elegans ProteinsTranscription FactorsC. elegansOocyte-to-embryo transitionSecretory pathwaySmall molecule

Identifiers

PMID27510972
PMCPMC5087616

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.